阿尔康因顶线失误下滑9%，更新2025年指引

2025-08-21 00:10

Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that missed on the top line.
In addition, the eye care company adjusted some of its 2025 guidance, including lowering net sales to $10.3B to $10.4B, down from $10.4B to $10.5B prior. Consensus is $10.47B.
Core diluted EPS remained at $3.05 to $3.15. Consensus is $3.11.
Q2 core diluted EPS of $0.76 compared to $0.74 in the year-ago period.
While revenues in vision care -- Alcon's largest business unit -- increased 4% year over year, in surgical care, the increase was only 2%.
Alcon ended the quarter with ~$1.4B in cash and cash equivalents compared to ~$1.7B on Dec. 31, 2024.

More on Alcon